Enhancement of lymphokine-activated killer cell induction using anti-CD25 and anti-CTLA-4 monoclonal antibodies
Riki Okita(National Sanyo Hospital), Tetsuya Toge(Hiroshima University), Yoshiyuki Yamaguchi(Hiroshima University), Akiko Emi(Hiroshima University), Kazuo Matsuura
Cited by 3
Related Papers
Current status of the molecular mechanisms of anticancer drug-induced apoptosis
|Cancer Chemotherapy and Pharmacology|2002|255
Targeted therapy against Bcl-2-related proteins in breast cancer cells
|Breast Cancer Research|2005|114
Experimental studies on biochemical modulation targeting topoisomerase I and II in human tumor xenografts in nude mice
|International Journal of Cancer|1992|111